BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16618109)

  • 1. Characterization of human saposins by NMR spectroscopy.
    John M; Wendeler M; Heller M; Sandhoff K; Kessler H
    Biochemistry; 2006 Apr; 45(16):5206-16. PubMed ID: 16618109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Saposin B mobilizes lipids from cholesterol-poor and bis(monoacylglycero)phosphate-rich membranes at acidic pH. Unglycosylated patient variant saposin B lacks lipid-extraction capacity.
    Remmel N; Locatelli-Hoops S; Breiden B; Schwarzmann G; Sandhoff K
    FEBS J; 2007 Jul; 274(13):3405-20. PubMed ID: 17561962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solution structure of human saposin C: pH-dependent interaction with phospholipid vesicles.
    de Alba E; Weiler S; Tjandra N
    Biochemistry; 2003 Dec; 42(50):14729-40. PubMed ID: 14674747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional characterization of the postulated intramolecular sphingolipid activator protein domain of human acid sphingomyelinase.
    Kölzer M; Ferlinz K; Bartelsen O; Hoops SL; Lang F; Sandhoff K
    Biol Chem; 2004 Dec; 385(12):1193-5. PubMed ID: 15653433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solution structure of human saposin C in a detergent environment.
    Hawkins CA; de Alba E; Tjandra N
    J Mol Biol; 2005 Mar; 346(5):1381-92. PubMed ID: 15713488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse testicular sulfated glycoprotein-1: sequence analysis of the common backbone structure of prosaposins.
    Zhao Q; Bell AW; El-Alfy M; Morales CR
    J Androl; 1998; 19(2):165-74. PubMed ID: 9570739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structures of human saposins C andD: implications for lipid recognition and membrane interactions.
    Rossmann M; Schultz-Heienbrok R; Behlke J; Remmel N; Alings C; Sandhoff K; Saenger W; Maier T
    Structure; 2008 May; 16(5):809-17. PubMed ID: 18462685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of recombinant human saposin A expressed by Pichia pastoris.
    Yamada M; Inui K; Hamada D; Nakahira K; Yanagihara K; Sakai N; Nishigaki T; Ozono K; Yanagihara I
    Biochem Biophys Res Commun; 2004 May; 318(2):588-93. PubMed ID: 15120640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformational and amino acid residue requirements for the saposin C neuritogenic effect.
    Qi X; Kondoh K; Krusling D; Kelso GJ; Leonova T; Grabowski GA
    Biochemistry; 1999 May; 38(19):6284-91. PubMed ID: 10320358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural changes in a binary mixed phospholipid bilayer of DOPG and DOPS upon saposin C interaction at acidic pH utilizing 31P and 2H solid-state NMR spectroscopy.
    Abu-Baker S; Qi X; Newstadt J; Lorigan GA
    Biochim Biophys Acta; 2005 Nov; 1717(1):58-66. PubMed ID: 16289479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of saposin D with membranes: effect of anionic phospholipids and sphingolipids.
    Ciaffoni F; Tatti M; Salvioli R; Vaccaro AM
    Biochem J; 2003 Aug; 373(Pt 3):785-92. PubMed ID: 12733985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct visualization of saposin remodelling of lipid bilayers.
    Alattia JR; Shaw JE; Yip CM; Privé GG
    J Mol Biol; 2006 Oct; 362(5):943-53. PubMed ID: 16949605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structures of the human ceramide activator protein saposin D.
    Popovic K; Privé GG
    Acta Crystallogr D Biol Crystallogr; 2008 May; 64(Pt 5):589-94. PubMed ID: 18453694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The saposin-like proteins 1, 2, and 3 of Fasciola gigantica.
    Grams R; Adisakwattana P; Ritthisunthorn N; Eursitthichai V; Vichasri-Grams S; Viyanant V
    Mol Biochem Parasitol; 2006 Aug; 148(2):133-43. PubMed ID: 16626816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accumulation of sphingolipids in SAP-precursor (prosaposin)-deficient fibroblasts occurs as intralysosomal membrane structures and can be completely reversed by treatment with human SAP-precursor.
    Burkhardt JK; Hüttler S; Klein A; Möbius W; Habermann A; Griffiths G; Sandhoff K
    Eur J Cell Biol; 1997 May; 73(1):10-8. PubMed ID: 9174667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acid sphingomyelinase possesses a domain homologous to its activator proteins: saposins B and D.
    Ponting CP
    Protein Sci; 1994 Feb; 3(2):359-61. PubMed ID: 8003971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structures of saposins A and C.
    Ahn VE; Leyko P; Alattia JR; Chen L; Privé GG
    Protein Sci; 2006 Aug; 15(8):1849-57. PubMed ID: 16823039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating the interaction of saposin C with POPS and POPC phospholipids: a solid-state NMR spectroscopic study.
    Abu-Baker S; Qi X; Lorigan GA
    Biophys J; 2007 Nov; 93(10):3480-90. PubMed ID: 17704143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of saposins A and C on the enzymatic hydrolysis of liposomal glucosylceramide.
    Vaccaro AM; Tatti M; Ciaffoni F; Salvioli R; Barca A; Scerch C
    J Biol Chem; 1997 Jul; 272(27):16862-7. PubMed ID: 9201993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Asn > Lys substitution in saposin B involving a conserved amino acidic residue and leading to the loss of the single N-glycosylation site in a patient with metachromatic leukodystrophy and normal arylsulphatase A activity.
    Regis S; Filocamo M; Corsolini F; Caroli F; Keulemans JL; van Diggelen OP; Gatti R
    Eur J Hum Genet; 1999; 7(2):125-30. PubMed ID: 10196694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.